The classic adenoma-carcinoma sequence thought to occur in LS-associated tumorigenesis has been challenged since recent reports have indicated that carriers of pathogenic MLH1 variants may undergo the so-called copy-neutral LOH which results in the simultaneous loss of CTNNB1 and MLH1 due to genomic rearrangement. The gene discussed is MLH1; the disease is Leigh syndrome.